ID
17653
Beskrivning
Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc ( OSI Pharmaceuticals ) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part: Withdrawal of Consent
Länk
https://clinicaltrials.gov/ct2/show/NCT00373425
Nyckelord
Versioner (2)
- 2016-08-02 2016-08-02 -
- 2016-09-27 2016-09-27 -
Uppladdad den
27 september 2016
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425
Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
Beskrivning
Withdrawal of Tissue Consent
Beskrivning
Withdrawal of Tissue Consent
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0475358
Beskrivning
Date Consent Withdrawn
Datatyp
date
Alias
- UMLS CUI [1,1]
- C1707492
- UMLS CUI [1,2]
- C0011008
Beskrivning
Withdrawal of Optional Research Blood Sample Consent
Beskrivning
Withdrawal of Optional Research Blood Sample Consent
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C0021430
- UMLS CUI [1,2]
- C0178913
Beskrivning
Date Consent Withdrawn
Datatyp
date
Alias
- UMLS CUI [1,1]
- C1707492
- UMLS CUI [1,2]
- C0011008
Beskrivning
Investigator Signature
Similar models
Withdrawal of Consent, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425
C0087111 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0475358 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
C0178913 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])